戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 merous reasons why errors and adverse events should be disclosed, and use of a standard framework for
2        Physicians agreed that harmful errors should be disclosed but "choose their words carefully" w
3 cate that, although most believe that errors should be disclosed, few routinely do so.
4 nfluence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled tri
5 nizing radiation during an imaging procedure should be disclosed to all patients by the ordering prov
6 eported that potential conflicts of interest should be disclosed to patients on research trials (52%
7 lieved that conflict of interest information should be disclosed to research participants.
8 elines, the allowable uses of GAI and how it should be disclosed varied substantially, with this hete